drugset / Trial / NCT03659149

Pharmacokinetics and Safety Profile of CKD-333

NCT03659149

Phase 1 Completed 37 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

Compare the pharmacokinetic characteristics and safety between CKD-333 tablet and CKD-330, D086 combination

Timeline

Start
2018-08-08
Primary completion
2018-10-05
Completion
2018-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-330 Unknown
Subject CKD-333 Unknown
Subject D086 Unknown